Cross-priming of CD8+ T cells stimulated by virus-induced type I interferon (original) (raw)

• Rodriguez, A., Regnault, A., Kleijmeer, M., Ricciardi-Castagnoli, P. & Amigorena, S. Selective transport of internalized antigens to the cytosol for MHC class I presentation in dendritic cells. Nat. Cell. Biol. 1, 362–368 (1999).
  Article CAS Google Scholar
• Heath, W.R. & Carbone, F.R. Cross-presentation, dendritic cells, tolerance and immunity. Annu. Rev. Immunol. 19, 47–64 (2001).
  Article CAS Google Scholar
• Kurts, C., Cannarile, M., Klebba, I. & Brocker, T. Dendritic cells are sufficient to cross-present self-antigens to CD8 T cells in vivo. J. Immunol. 166, 1439–1442 (2001).
  Article CAS Google Scholar
• Belz, G.T. et al. The CD8a+ dendritic cell is responsible for inducing peripheral self-tolerance to tissue-associated antigens. J. Exp. Med. 196, 1099–1104 (2002).
  Article CAS Google Scholar
• Jung, S. et al. In vivo depletion of CD11c+ dendritic cells abrogates priming of CD8 T cells by exogenous cell-associated antigens. Immunity 17, 211–220 (2002).
  Article CAS Google Scholar
• Bevan, M.J. Cross-priming for a secondary cytotoxic response to minor H antigens with H-2 congenic cells which do not cross-react in the cytotoxic assay. J. Exp. Med. 143, 1283–1288 (1976).
  Article CAS Google Scholar
• Gordon, R.D., Mathieson, B.J., Samelson, L.E., Boyse, E.A. & Simpson, E. The effect of allogeneic presensitization on H-Y graft survival and in vitro cell-mediated responses to H-Y antigen. J. Exp. Med. 144, 810–820 (1976).
  Article CAS Google Scholar
• Gooding, L.R. & Edwards, C.B. H-2 antigen requirements in the in vitro induction of SV40-specific cytotoxic lymphocytes. J. Immunol. 124, 1258–1262 (1980).
  CAS PubMed Google Scholar
• Carbone, F.R. & Bevan, M.J. Class I-restricted processing and presentation of exogenous cell-associated antigen in vivo. J. Exp. Med. 171, 377–387 (1990).
  Article CAS Google Scholar
• Kurts, C., Kosaka, H., Carbone, F.R., Miller, J.F.A.P. & Heath, W.R. Class I-restricted cross-presentation of exogenous self-antigens leads to deletion of autoreactive CD8+ T cells. J. Exp. Med. 186, 239–245 (1997).
  Article CAS Google Scholar
• Bennett, S.R.M., Carbone, F.R., Karamalis, F., Miller, J.F.A.P. & Heath, W.R. Induction of a CD8+ cytotoxic T lymphocyte response by cross-priming requires cognate CD4+ T cell help. J. Exp. Med. 186, 65–70 (1997).
  Article CAS Google Scholar
• Bennet, S.R.M. et al. Help for cytotoxic-T-cell responses is mediated by CD40 signalling. Nature 393, 478–480 (1998).
  Article Google Scholar
• Schoenberger, S.P., Toes, R.E.M., van der Voort, E.I.H., Offringa, R. & Melief, C.J.M. T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions. Nature 393, 480–483 (1998).
  Article CAS Google Scholar
• Ridge, J.P., Di Rosa, F. & Matzinger, P. A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell. Nature 393, 474–478 (1998).
  Article CAS Google Scholar
• Liu, K. et al. Immune tolerance after delivery of dying cells to dendritic cells in situ. J. Exp. Med. 196, 1091–1097 (2002).
  Article CAS Google Scholar
• Mazzaccaro, R.J. et al. Major histocompatibility class I presentation of soluble antigen facilitated by Mycobacterium tuberculosis infection. Proc. Natl. Acad. Sci. USA 93, 11786–11791 (1996).
  Article CAS Google Scholar
• Simmons, C.P. et al. MHC class I-restricted cytotoxic lymphocyte responses induced by enterotoxin-based mucosal adjuvants. J. Immunol. 163, 6502–6510 (1999).
  CAS PubMed Google Scholar
• Cho, H.J. et al. Immunostimulatory DNA-based vaccines induce cytotoxic lymphocyte activity by a T-helper cell-independent mechanism. Nat. Biotechnol. 18, 509–514 (2000).
  Article CAS Google Scholar
• Hamilton, S.E., Tvinnereim, A.R. & Harty, J.T. Listeria monocytogenes infection overcomes the requirement for CD40 ligand in exogenous antigen presentation to CD8+ T cells. J. Immunol. 167, 5603–5609 (2001).
  Article CAS Google Scholar
• Sigal, L.J., Crotty, S., Andino, R. & Rock, K.L. Cytotoxic T-cell immunity to virus-infected non-haematopoietic cells requires presentation of exogenous antigen. Nature 398, 77–80. (1999).
  Article CAS Google Scholar
• Mueller, S.N., Jones, C.M., Smith, C.M., Heath, W.R. & Carbone, F.R. Rapid cytotoxic T lymphocyte activation occurs in the draining lymph nodes after cutaneous herpes simplex virus infection as a result of early antigen presentation and not the presence of virus. J. Exp. Med. 195, 651–656 (2002).
  Article CAS Google Scholar
• Goodbourn, S., Didcock, L. & Randall, R.E. Interferons: cell signalling, immune modulation, antiviral responses and virus countermeasures. J. Gen. Virol. 81, 2341–2364 (2000).
  Article CAS Google Scholar
• Siegal, F.P. et al. The nature of the principal type 1 interferon-producing cells in human blood. Science 284, 1835–1837 (1999).
  Article CAS Google Scholar
• Luft, T. et al. Type I IFNs enhance the terminal differentiation of dendritic cells. J. Immunol. 161, 1947–1953 (1998).
  CAS PubMed Google Scholar
• Gallucci, S., Lolkema, M. & Matzinger, P. Natural adjuvants: Endogenous activators of dendritic cells. Nat. Med. 5, 1249–1255 (1999).
  Article CAS Google Scholar
• Ito, T. et al. Differential regulation of human blood dendritic cell subsets by IFNs. J. Immunol. 166, 2961–2969 (2001).
  Article CAS Google Scholar
• Le Bon, A. et al. Type I interferons potently enhance humoral immunity and can promote isotype switching by stimulating dendritic cells in vivo. Immunity 14, 461–470 (2001).
  Article CAS Google Scholar
• Montoya, M. et al. Type I interferons produced by dendritic cells promote their phenotypic and functional activation. Blood 99, 3263–3271 (2002).
  Article CAS Google Scholar
• von Hoegen, P., Zawatzky, R. & Schirrmacher, V. Modification of tumor cells by a low dose of Newcastle disease virus. III. Potentiation of tumor-specific cytolytic T cell activity via induction of interferon-α/β. Cell. Immunol. 126, 80–90. (1990).
  Article CAS Google Scholar
• Ferrantini, M. et al. IFN-α1 gene expression into a metastatic murine adenocarcinoma (TS/A) results in CD8+ T cell mediated tumor rejection and development of antitumor immunity. Comparative studies with IFN-γ-producing TS/A cells. J. Immunol. 153, 4604–4615 (1994).
  CAS PubMed Google Scholar
• Tough, D.F., Borrow, P. & Sprent, J. Induction of bystander T cell proliferation by viruses and type I interferon in vivo. Science 272, 1947–1950 (1996).
  Article CAS Google Scholar
• Van Uden, J.H., Tran, C.H., Carson, D.A. & Raz, E. Type I interferon is required to mount an adaptive response to immunostimulatory DNA. Eur. J. Immunol. 31, 3281–3290 (2001).
  Article CAS Google Scholar
• Cho, H.J. et al. IFN-αβ promote priming of antigen-specific CD8+ and CD4+ T lymphocytes by immunostimulatory DNA-based vaccines. J. Immunol. 168, 4907–4913 (2002).
  Article CAS Google Scholar
• Hogquist, K.A. et al. T cell receptor antagonist peptides induce positive selection. Cell 76, 17–27 (1994).
  Article CAS Google Scholar
• Merigan, T.C., Oldstone, M.B. & Welsh, R.M. Interferon production during lymphocytic choriomeningitis virus infection of nude and normal mice. Nature 268, 67–68 (1977).
  Article CAS Google Scholar
• Korngold, R., Blank, K.J. & Murasko, D.M. Effect of interferon on thoracic duct lymphocyte output: Induction with either poly I:poly C or vaccinia virus. J. Immunol. 130, 2236–2240 (1983).
  CAS PubMed Google Scholar
• Moore, M.W., Carbone, F.R. & Bevan, M.J. Introduction of soluble protein into the class I pathway of antigen processing and presentation. Cell 54, 777–785 (1988).
  Article CAS Google Scholar
• Lefrancois, L., Altman, J.D., Williams, K. & Olson, S. Soluble antigen and CD40 triggering are sufficient to induce primary and memory cytotoxic T cells. J. Immunol. 164, 725–732 (2000).
  Article CAS Google Scholar
• Lu, Z. et al. CD40-independent pathways of T cell help for priming of CD8+ cytotoxic T lymphocytes. J. Exp. Med. 191, 541–550 (2000).
  Article CAS Google Scholar
• Zhan, Y., Corbett, A.J., Brady, J.L., Sutherland, R.M. & Lew, A.M. CD4 help-independent induction of cytotoxic CD8 cells to allogeneic P815 tumor cells is absolutely dependent on costimulation. J. Immunol. 165, 3612–3619 (2000).
  Article CAS Google Scholar
• Bourgeois, C., Rocha, B. & Tanchot, C. A role for CD40 expression on CD8+ T cells in the generation of CD8+ T cell memory. Science 297, 2060–2063 (2002).
  Article CAS Google Scholar
• Janssen, E.M. et al. CD4+ T cells are required for secondary expansion and memory in CD8+ T lymphocytes. Nature 421, 852–856 (2003).
  Article CAS Google Scholar
• Sun, J.C. & Bevan, M.J. Defective CD8 T cell memory following acute infection without CD4 T cell help. Science 300, 339–342 (2003).
  Article CAS Google Scholar
• Shedlock, D.J. & Shen, H. Requirement for CD4 T cell help in generating functional CD8 T cell memory. Science 300, 337–339 (2003).
  Article CAS Google Scholar
• Josien, R. et al. TRANCE, a tumor necrosis factor family member, enhances the longevity and adjuvant properties of dendritic cells in vivo. J. Exp. Med. 191, 495–502 (2000).
  Article CAS Google Scholar
• Bevan, M.J. Immunology. Stimulating killer cells. Nature 342, 478–479 (1989).
  Article CAS Google Scholar
• Jamaluddin, M. et al. IFN-β mediates coordinate expression of antigen-processing genes in RSV-infected pulmonary epithelial cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 280, L248–L257 (2001).
  Article CAS Google Scholar
• Dutko, F.J. & Oldstone, M.B. Genomic and biological variation among commonly used lymphocytic choriomeningitis virus strains. J. Gen. Virol. 64, 1689–1698 (1983).
  Article CAS Google Scholar
• Chakrabarti, S., Brechling, K. & Moss, B. Vaccinia virus expression vector: coexpression of β-galactosidase provides visual screening of recombinant virus plaques. Mol. Cell. Biol. 5, 3403–3409 (1985).
  Article CAS Google Scholar
• Restifo, N.P. et al. Antigen processing in vivo and the elicitation of primary CTL responses. J. Immunol. 154, 4414–4422 (1995).
  CAS PubMed PubMed Central Google Scholar